Predicting mortality with pneumonia severity scores: Importance of model recalibration to local settings

Epidemiology and Infection

Volumn 136, Issue 12, 2008, Pages 1628-1637

  Schuetz, P ^a   Koller, M ^a   Christ Crain, M ^a   Steyerberg, E ^b   Stolz, D ^c   Muller C ^a   Bucher, H C ^a   Bingisser, R ^a   Tamm, M ^c   Muller B ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREATHING RATE; CALIBRATION; CLINICAL ASSESSMENT TOOL; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; PNEUMONIA SEVERITY INDEX; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL MODEL; SWITZERLAND; TERTIARY HEALTH CARE; UREA BLOOD LEVEL;

AGED; AGED, 80 AND OVER; CALIBRATION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PNEUMONIA; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWITZERLAND;

EID: 56349139109     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268808000435     Document Type: Article

References (26)

1. Macfarlane JT, et al. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993; 341: 511-514.
2. Dixon RE. Economic costs of respiratory tract infections in the United States. American Journal of Medicine 1985; 78: 45-51.
3. Niederman MS, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. American Journal of Respiratory and Critical Care Medicine 2001; 163: 1730-1754.
4. Woodhead M, et al. Guidelines for the management of adult lower respiratory tract infections. European Respiratory Journal 2005; 26: 1138-1180.
5. Fine MJ, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine 1997; 336: 243-250.
6. Lim WS, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: Implications for management guidelines. Thorax 2001; 56: 296-301.
7. Lim WS, et al. De.ning community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 2003; 58: 377-382.
8. Neill AM, et al. Community acquired pneumonia: Aetiology and usefulness of severity criteria on admission. Thorax 1996; 51 1010-1016.
9. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Annals of Internal Medicine 1999; 130: 515-524.
10. Flanders WD, et al. Validation of the pneumonia severity index. Importance of study-speci.c recalibration. Journal of General Internal Medicine 1999; 14: 333-340.
11. Yan Man S, et al. Prospective comparison of three predictive rules for assessing severity of communityacquired pneumonia in Hong Kong. Thorax 2007; 62: 348-353.
12. Capelastegui A, et al. Validation of a predictive rule for the management of community-acquired pneumonia. European Respiratory Journal 2006; 27: 151-157.
13. Marras TK, Gutierrez C, Chan CK. Applying a prediction rule to identify low-risk patients with communityacquired pneumonia. Chest 2000; 118: 1339-1343.
14. Buising KL, et al. A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: Reconsidering what is meant by severe pneumonia. Thorax 2006; 61: 419-424.
15. Ewig S, et al. Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004; 59: 421-427.
16. Spindler C, Ortqvist A. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. European Respiratory Journal 2006; 28: 816-823.
17. Aujesky D, et al. Prospective comparison of three validated prediction rules for prognosis in communityacquired pneumonia. American Journal of Medicine 2005; 118: 384-392.
18. Christ-Crain M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-607.
19. Christ-Crain M, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. American Journal of Respiratory and Critical Care Medicine 2006; 174: 84-93.
20. Steyerberg EW, et al. Validation and updating of predictive logistic regression models: A study on sample size and shrinkage. Statistics in Medicine 2004; 23: 2567-2586.
21. Steyerberg EW, et al. Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis. Journal of Clinical Epidemiology 2001; 54: 774-781.
22. Poses RM, Cebul RD, Centor RM. Evaluating physicians' probabilistic judgments. Medical Decision Making 1988; 8: 233-240.
23. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2006.
24. Harrell FE. Design: Design Package. R package version 2.0-12, 2005.
25. van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Statistics in Medicine 2000; 19: 3401-3415.
26. Vergouwe Y, et al. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. Journal of Clinical Epidemiology 2005; 58 475-483.